Montse Sánchez‐Céspedes

机构：Universitat Autònoma de Barcelona, Josep Carreras Leukaemia Research Institute, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ORCID：0000-0002-6045-5627

发表论文 277 篇 · 总被引 22002 次 · h-index 62

代表论文

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer (2023 · Cell Reports Medicine · 被引 37)
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC (2025 · Journal of Thoracic Oncology · 被引 18)
Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C (2023 · Frontiers in Oncology · 被引 9)
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer (2024 · Lung Cancer · 被引 6)
DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy (2024 · Journal of Thoracic Oncology · 被引 5)
Supplementary Table S1 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption (2026)